Cargando…
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in controlling HIV-1 infections, new drug ta...
Autores principales: | Wapling, Johanna, Srivastava, Seema, Shehu-Xhilaga, Miranda, Tachedjian, Gilda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155237/ https://www.ncbi.nlm.nih.gov/pubmed/21901072 |
Ejemplares similares
-
Properties and Functions of Feline Immunodeficiency Virus Gag Domains in Virion Assembly and Budding
por: González, Silvia A., et al.
Publicado: (2018) -
Assembly and budding of influenza virus
por: Nayak, Debi P., et al.
Publicado: (2004) -
ESCRT‐II functions by linking to ESCRT‐I in human immunodeficiency virus‐1 budding
por: Meng, Bo, et al.
Publicado: (2020) -
Host cytoskeleton in respiratory syncytial virus assembly and budding
por: Shahriari, Shadi, et al.
Publicado: (2016) -
Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)